United States · Industrial & Consumer Products · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
164.78%
2025 (actual)
ROA
-32.12%
2025 (actual)
Gross Margin
-376.05%
2025 (actual)
Net Margin
-
Total Assets
$116,366.00K
2025 (actual)
Net Income
-$40,833.00K
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
-136.8 pt
Company
Sector average (own scale)
ROA
-142.5 pt
Company
Gross Margin
-128 pt
Company
Sector average (own scale)
Total Assets
-8.3%
Company
Sector average (own scale)
Net Income
-347.4%
Company
Detailed data
USD|Thousands
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Humacyte, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.